Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1344 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-uPA Receptor/PLAUR Antibody
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for uPAR/PLAUR detection. Host: Rabbit.Size: 100μg/vial. Tested applications: IHC-P. Reactive species: Human. uPAR/PLAUR information: Molecular Weight: 36978 MW; Subcellular Localization: Cell membrane . Cell projection, invadopodium membrane . Colocalized with FAP (seprase) preferentially at the cell surface of invadopodia membrane in a cytoskeleton-, integrin- and vitronectin-dependent manner; Tissue Specificity: Expressed in neurons of the rolandic area of the brain (at protein level). Expressed in the brain.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Construction of Urokinase-Type Plasminogen Activator Receptor-Targeted Heterostructures for Efficient Photothermal Chemotherapy against Cervical Cancer To Achieve Simultaneous Anticancer and Antiangiogenesis.
Apigenin Suppresses the IL-1β-Induced Expression of the Urokinase-Type Plasminogen Activator Receptor by Inhibiting MAPK-Mediated AP-1 and NF-κB Signaling in Human Bladder Cancer T24 Cells.
Effects of uPA on mesangial matrix changes in the kidney of diabetic rats.
Hu X, Mandika C, He L, You Y, Chang Y, Wang J, Chen T, Zhu X
ACS applied materials & interfaces 2019 Oct 30;11(43):39688-39705
ACS applied materials & interfaces 2019 Oct 30;11(43):39688-39705
Apigenin Suppresses the IL-1β-Induced Expression of the Urokinase-Type Plasminogen Activator Receptor by Inhibiting MAPK-Mediated AP-1 and NF-κB Signaling in Human Bladder Cancer T24 Cells.
Xia Y, Yuan M, Li S, Thuan UT, Nguyen TT, Kang TW, Liao W, Lian S, Jung YD
Journal of agricultural and food chemistry 2018 Jul 25;66(29):7663-7673
Journal of agricultural and food chemistry 2018 Jul 25;66(29):7663-7673
Effects of uPA on mesangial matrix changes in the kidney of diabetic rats.
Cheng H, Chen C, Wang S
Renal failure 2014 Sep;36(8):1322-7
Renal failure 2014 Sep;36(8):1322-7
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- Anti-uPA Receptor antibody, PA1344, Western blottingLane 1: MCF-7 Cell Lysate Lane 2: HELA Cell Lysate Lane 3: RAJI Cell Lysate Lane 4: SMMC Cell Lysate
- Additional image